Skip to content
Menu

DESyne X2

DESyne X2 Novolimus Eluting Coronary Stent System

The DESyne® X2 NovolimusTM Eluting Coronary Stent System is a low-profile DES with high flexibility and exceptional deliverability. The ultra-thin design of its stent and polymer coating, with no primer coating, results in one of the thinnest coated struts available.

Hover over the icons to learn more about DESyne X2 design.

DESyne X2 is not approved by the United States Food and Drug Administration (FDA).

DESYne-X2_Elixir-Medical-Coronary-Artery-Disease-softedge

DESyne Clinical Study

EXCELLA II Randomized Controlled Trial

Study Design

  • 21 sites
  • 210 Patients Randomized 2:1 DESyne DES vs. Endeavor DES
    (Europe, New Zealand, Australia)

At five-year follow-up, the incidence of device- and patient-oriented events was significantly lower in the Novolimus stent (DESyne) group.

EXCELLA II 5 year outcomes published in Eurointervention, December 2016
PMN 582 Rev A